mLabs  Cardiac 3 Panel

Rapid Diagnosis and Management of Myocardial Infarctions

 

 

Chest pain accounts for millions of admissions to emergency rooms in the US annually. Up to 85% of these patients are not actually suffering from myocardial Infarction (MI). A great deal of time and money is spent stratifying these millions of patients. 3-in-1 panels of all three cardiac markers could provide a result more rapidly after onset of symptoms in order to rule out MI. This would enable patients who do not have an MI to be discharged, easing the financial burden and time spent attending to patients without acute needs.

 

Micropoint's mLabs Cardiac 3 Panel rapidly provides diagnostic information to differentiate acute myocardial infarction from other cardiac abnormalities. It can improve clinical, economic and operational outcomes, and reduce unnecessary hospital admissions, costs and length of stay.

 

Clinical Applications:

  • Differentiation of MI from other cardiac abnormalities

  • Assistance in rapid clinical treatment decisions

 

Cardiac Panel 3 Resources:

 

Datasheet

Control Insert

Assay Insert

Training Video

 

mLabs Cardiac Panel 3 test is CE marked and distributed outside of the US.

 

 

 

To contact Micropoint to find out more or to purchase mLabs Cardiac Panel 3 test, please email: info@micropointbio.com.

®

 

 

U.S. Headquarters

 

Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States

 

T:+1 (408) 588-1682
F:+1 (408) 588-1620

 

 

European Office

 

Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble

France 

 

T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office

 

Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong

China

 

T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.